The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 13 May 2008, www.theannals.com, DOI 10.1345/aph.1K617.
The Annals of Pharmacotherapy: Vol. 42, No. 6, pp. 861-868. DOI 10.1345/aph.1K617
© 2008 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, A. S
Right arrow Articles by Aslani, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, A. S
Right arrow Articles by Aslani, P.

Practice Change in Community Pharmacy: Quantification of Facilitators

Alison S Roberts, BPharm(Hons) PhD

Research Fellow, The University of Sydney, New South Wales, Australia

Shalom I Benrimoj, BPharm(Hons) PhD

Pro-Vice-Chancellor (Strategic Planning), The University of Sydney

Timothy F Chen, BPharm DipHPharm PhD

Senior Lecturer, Faculty of Pharmacy, The University of Sydney

Kylie A Williams, BPharm DipHPharm PhD

Lecturer, Faculty of Pharmacy, The University of Sydney

Parisa Aslani, BPharm(Hons) MSc PhD

Senior Lecturer, Faculty of Pharmacy, The University of Sydney

Reprints: Dr. Roberts, The University of Sydney, NSW 2006 Australia, fax 61 2 93514391, roberts_alison{at}bigpond.com


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 Limitations
 Conclusions
 References
 
BACKGROUND: There has been an increasing international trend toward the delivery of cognitive pharmaceutical services (CPS) in community pharmacy. CPS have been developed and disseminated individually, without a framework underpinning their implementation and with limited knowledge of factors that might assist practice change. The implementation process is complex, involving a range of internal and external factors.

OBJECTIVE: To quantify facilitators of practice change in Australian community pharmacies.

METHODS: We employed a literature review and qualitative study to facilitate the design of a 43-item "facilitators of practice change" scale as part of a quantitative survey instrument, using a framework of organizational theory. The questionnaire was pilot-tested (n = 100), then mailed to a random sample of 2000 community pharmacies, with a copy each for the pharmacy owner, employed pharmacist, and pharmacy assistant. The construct validity and reliability of the scale were established using exploratory factor analysis and Cronbach's {alpha}, respectively.

RESULTS: A total of 735 (37%) pharmacies responded, with 1303 individual questionnaires. Factor analysis of the scale yielded 7 factors, explaining 48.8% of the total variance. The factors were: relationship with physicians (item loading range 0.59–0.85; Cronbach's {alpha} 0.90), remuneration (0.52–0.74; 0.82), pharmacy layout (0.52–0.79; 0.81), patient expectation (0.52–0.85; 0.82), manpower/staff (0.49–0.66; 0.80), communication and teamwork (0.37–0.65; 0.77), and external support/assistance (0.47–0.69; 0.74).

CONCLUSIONS: All of the factors demonstrated good reliability and construct validity and explained approximately half of the variance. Implementing CPS requires support not only with the clinical aspects of service delivery, but also for the process of implementation itself, and remuneration models must reflect this. The identified facilitators should be used in a multilevel strategy to integrate professional services into the community pharmacy business, engaging pharmacists and their staff, policy makers, educators, and researchers. Further research is required to determine additional factors impacting the capacity of community pharmacies to implement change.

Key Words: cognitive pharmaceutical services, community pharmacy

Published Online, May 13, 2008. www.theannals.com, DOI 10.1345/aph.1K617


The international pharmacy practice literature has documented shifts in the orientation of community pharmacy practice over the past century along a continuum of manufacturing, compounding, and distribution to clinical services, pharmaceutical care, and more recently, cognitive pharmaceutical services (CPS).1 CPS are professional services provided by pharmacists, using their skills and knowledge to take an active role in contributing to patient health through effective interaction with both patients and other health professionals.2 Community pharmacy in Australia has been at the forefront of this international trend toward the delivery of remunerated CPS. Since 1990, the profession has negotiated 5-year Community Pharmacy Agreements with the Australian government. These agreements cover all aspects of remuneration for community pharmacies and have created an increased focus on CPS provision.3 The agreements have been significant drivers of practice change, which, in this context, refers to the shift in focus from product supply to patient-centered service delivery. The factors causing this shift are complex and include issues such as changes in government policy, resulting in declining profit margins on prescription products, leading to the development of other income sources to ensure sustainability.4

CPS programs appear to have been developed and disseminated individually, without a framework underpinning their implementation or inclusion of factors that might facilitate practice change. One of the major implications of this is reduced uptake of CPS. Significant attention has been given to barriers to CPS adoption, focusing largely at the practitioner level. A review of facilitators of practice change in community pharmacy concluded that there is a need to clarify how identified facilitators (defined as elements that make adopting a new behavior or practice easier) can be used in practice to accelerate the implementation of CPS.2 The factors affecting change are more than just those confined to the individual pharmacist who is being trained through traditional, clinically focused, didactic education programs to provide CPS. Broader educational, social, and financial factors are involved,4 and thus research that adopts an organizational perspective is needed. This approach, successfully used in other healthcare settings,5-7 allows the identification of factors affecting practice change beyond the perspective of the individual pharmacist, as aspects such as culture, structure, and the environment are brought into consideration.8,9 The aim of our research, therefore, was to identify the key components needed for the development of a practice change model for Australian community pharmacies. The specific objectives were to develop and validate an instrument to allow the identification and quantification of facilitators of practice change, drawing on the experiences of those involved with existing community pharmacy services and programs (Table 110). This approach was different from that of previous studies in which services have been more loosely defined, and the proportion of respondents with experience of the services has been low; hence, facilitators have sometimes been based on perception rather than experience.2,11


View this table:
[in this window]
[in a new window]

 
Table 1. Professional Practice Programs in the Third Community Pharmacy Agreement (2000–2005)10

 


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 Limitations
 Conclusions
 References
 
THEORETICAL FRAMEWORK
A broad framework of organizational theory was used to identify factors that affect practice change from a community pharmacy perspective and to assist in better understanding the change process for the whole pharmacy.9 This theoretical framework was the underpinning for a qualitative study, the results of which were used to generate items for the quantitative research instrument.12

INSTRUMENT DESIGN
Literature reviews2,13 and data from the qualitative study12 facilitated the design of a structured questionnaire, with sections that include adoption of Third Agreement Programs4 (Table 1), facilitators of practice change scale (facilitators scale) consisting of 74 items based on 13 constructs that are measured using a 5-point Likert scale ranging from Strongly Disagree (1) to Strongly Agree (5), individual respondent and pharmacy demographics, and free comments.

INSTRUMENT VALIDITY AND RELIABILITY TESTING
The content and construct validity of the questionnaire were established in a pilot mail survey of a random sample of Australian community pharmacies (N = 100).14 To test construct validity, factor analysis was performed on the data from the facilitators scale. Factor analysis is a technique used to reduce a set of observed variables to a smaller number of underlying factors.15 The internal consistency or reliability of the factors was measured using Cronbach's {alpha}. The results of these analyses allowed changes to be made to the research instrument and a sample size to be calculated for the main study.14

POPULATION AND SAMPLE
Ethics approval for the research was obtained from the Human Research Ethics Committee at the University of Sydney. Contact details of all Australian community pharmacies (N = 4926) were obtained from the Pharmacy boards and the telephone directory. (Pharmacy boards are regulatory authorities in the 6 states and 2 territories within Australia and are responsible for the registration of pharmacists and approval of pharmacy premises.) Calculations were based on the sample needed to detect statistically significant differences (p < 0.05) between mean facilitator factor scores for certain individual variables (eg, role) and pharmacy variables (eg, adopter category) deemed to be of practical importance, based on data from the pilot study.14 At 80% power (p = 0.05), 1130 individual responses were needed, more than that required to perform factor analysis.16 Based on the pilot survey, there was an expectation of receiving 1.7 individual responses per pharmacy; therefore, to achieve the required sample size of 1130, 657 pharmacies would need to respond. At an anticipated response rate of 33%, a total of 2000 pharmacies were randomly sampled (stratified by state).

The mail survey was conducted using the standardized process described by Dillman.17 In keeping with the organizational perspective, each pharmacy was sent 3 questionnaires, one each for a pharmacy owner, an employed pharmacist, and a pharmacy assistant (including technicians).

RESPONSE
A total of 735 pharmacies responded (37% response rate), with 1303 individual responses received (Table 2). Of the respondents, 957 (73%) were pharmacists, who were representative of the total population in terms of age and sex.18 Of that group, 585 (61%) were proprietors. This proportion was significantly higher than the 45% in the population of community pharmacists ({chi}2 = 10.34; p = 0.001), which may be due to the fact that the questionnaire was sent to pharmacies, not to individual pharmacists, and not all pharmacies returned multiple questionnaires.


View this table:
[in this window]
[in a new window]

 
Table 2. Respondents' Roles/Positions in the Pharmacy

 

DATA ANALYSIS
Factor analysis was performed on the facilitators scale. Examination of the correlation matrix indicated that all items had a correlation greater than or equal to |0.30| with at least 3 other items in the matrix.15 Bartlett's Test of Sphericity was significant ({chi}2 = 17655.21; p < 0.001), and the KMO measure of sampling adequacy was 0.89. Principle axis factoring was the method of extraction used, with equamax orthogonal rotation, as many correlations were less than 0.32.19 The eigenvalue greater than 1 rule, visual inspection of the scree plot, and the number of items loading well on the factor were all used to determine how many factors to retain.15,20 Some items were removed due to poor loading (<0.30) or cross-loading. The decision of item retention was assisted by the use of Cronbach's {alpha}, to see whether the coefficient would be positively affected by the removal of an item.15 Factor scores were calculated using the weighted factor-based scales method, which takes the factor loadings into account so that items with the highest loadings contribute the most to the factor score.16,21


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 Limitations
 Conclusions
 References
 
FACTOR ANALYTICAL MODEL
Seven facilitators were identified (Table 3). This factor solution explained 48.8% of the total variance (Table 4), and although there are no definitive guidelines as to what constitutes an appropriate amount of variance explained, this result can be considered good.15,22 Each of the factors was judged as reliable, having a Cronbach's {alpha} of greater than 0.7 (Table 4). In all cases, the factor-based scales were non-normally distributed. The median factor score was higher than the midpoint of the new scale range, which indicated that the majority of respondents were in agreement with the items forming that factor.


View this table:
[in this window]
[in a new window]

 
Table 3. Factor Loadings of Items in the Seven-Factor Solution from the Facilitators Scalea

 

View this table:
[in this window]
[in a new window]

 
Table 4. Characteristics of the Seven-Factor Solution–Facilitators of Practice Change

 


    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 Limitations
 Conclusions
 References
 
Our study identified 7 facilitators of practice change. Although some of them have previously been identified individually, they have not been presented as elements of a total solution, with little effort given toward exploring how they could be integrated for use in practice, particularly at the different organizational levels.2 Furthermore, the facilitators identified in this study were based on existing programs disseminated to community pharmacies, and participants responded based on their actual experience of implementing the programs. The facilitators are therefore discussed below with specific emphasis on their practical application and relevance for key stakeholder groups.

RELATIONSHIP WITH PHYSICIANS
Items that constituted this factor referred to the role of pharmacist–physician relationships for the implementation of new programs, suggesting that building rapport with local physicians was important to the program's success. This factor contributed almost half of the total solution, which is not surprising given that the main CPS experience for most pharmacies related to home medicines review (HMR), a service involving collaboration between physicians and pharmacists (Table 1). There needs to be greater focus on the development and maintenance of cooperative relationships between pharmacists and physicians at the local level; this relationship is known to be a key facilitator in the shift toward a greater service orientation and for a range of programs and services.2 At the political level, policies need to be developed and corresponding structures put in place to connect pharmacists and physicians across all levels, from professional organizations to local networks. Pharmacists themselves need to work toward this goal. For example, the "arms-length" model of medication review delivery adopted by many pharmacies, which essentially sees a third party having the main communication with physicians,23 could hinder the development of collaborative relationships.

REMUNERATION
Statements in the questionnaire referred to remuneration either as incentive payments to assist with the implementation process or payment for the delivery of a service itself, with both concepts shown to be important. In the case of HMR, remuneration was provided for delivery of the service only and did not address wider issues related to implementation and sustainability. This is evident from the data on HMR delivery, showing that, although nearly all Australian community pharmacies had registered to be part of the HMR program, the actual rate of participation and service delivery appeared to be low.23

PHARMACY LAYOUT
The items that made up this factor referred to the importance of the physical layout of the pharmacy relative to the implementation of programs. Some items specifically referred to the need for a private or designated area for delivery of certain services. An appropriate pharmacy layout, in terms of space and privacy, has been highlighted in the literature as a potential facilitator concerning a range of CPS.2 Many European countries have designated areas in pharmacies specifically for the delivery of services such as disease state management. Policy makers in Australia have reacted to this research and have adopted the position that an appropriate pharmacy layout is a prerequisite for participation in a number of remunerated programs.24

PATIENT EXPECTATION
The concept of consumer demand for services was explored in the items that made up this factor, suggesting not only that there is a perception that the public expects pharmacies to offer certain services, but also that this acts as a facilitator in the implementation of those services. This finding is consistent with the traditional functions of pharmacies as part of their supply role and place in a retail environment, that is, reacting to the needs of their customers or facing negative financial consequences. It follows that, if patients expect a certain service, the pharmacy will feel both obliged and motivated to provide it.

MANPOWER/STAFF
Items loading on this factor suggested that having sufficient and appropriately trained staff was a key element of, and necessary for, successful implementation. Workforce shortages were a particular problem in Australia at the time of the study,25 and discussions in the literature suggest that it is also a problem internationally, with few solutions proposed.26-30 Closely linked to this issue is the workload generated by the implementation of new programs and the resultant need for additional staff. However, this is not the complete solution. If new initiatives are introduced to community pharmacy in an ad hoc manner, without any integration, the workload will simply increase each time a new program is commenced. This is important for policy makers to consider during the planning phases; they should assess the workforce requirements not only in terms of numbers, but also with regard to knowledge, skills, and competencies. To avoid putting existing services at risk, pharmacies must be assisted in preparing for the adoption of each new service prior to its dissemination.

COMMUNICATION AND TEAMWORK
Statements that made up this factor referred to the importance of communicating the reasons for change internally, working as a team to make it happen, and having someone to lead the change. Previous strategies for implementing CPS in community pharmacy seem to have largely focused on the pharmacy owner as the agent of change. It is now clear that, although the owners may take a leadership role at the pharmacy level, the change process is facilitated by engaging the entire pharmacy team and allowing the development of common goals toward which all members of the organization are working. These concepts, together with leadership, are common elements among many organizational change models.13 Policy makers should be aware of this in developing strategies for the dissemination of new programs or services, and educators should include these elements in training provided to pharmacists. Pharmacy owners should also be cognizant of the need to include their entire staff in the implementation process, even for a service that is ostensibly delivered only by the pharmacist, and should include staff members in the processes of planning and goal setting.

EXTERNAL SUPPORT AND ASSISTANCE
For this factor, items highlighted the importance of being able to call on experts and/or consultants, often from outside pharmacy, when planning and implementing change. This finding is of particular relevance to professional pharmacy organizations in that they play a key role in providing support to pharmacists. Implementing new CPS requires support not only with the clinical aspects of service delivery, but also with the process of implementation. For example, pharmacies may need assistance in the process of common goal setting or changing the pharmacy layout and workflow. Mentoring programs, which allow pharmacists to gain assistance from other pharmacists and have been highlighted by others as facilitators of change, should be supported by policy makers and the profession as a whole.2

Although further research is required to determine additional factors that are affecting the implementation of CPS, the facilitators identified in this study have been adopted by policy makers in Australia as components of a multilevel practice change strategy for the implementation of remunerated CPS in Australian community pharmacies.31 The findings also have international applicability; while previous research has identified some of these facilitators individually in other countries,2 this study provides a practical framework for their application by the different organizational players.


    Limitations
 Top
 Abstract
 Methods
 Results
 Discussion
 Limitations
 Conclusions
 References
 
The model for facilitators identified through factor analysis was developed using data from all respondents to give an organizational perspective, incorporating the views of the individuals within it. A potential limitation of this approach, however, is that pharmacy assistants (25% of respondents) were included, and they may play only a limited role in the provision of Third Agreement Programs other than the Quality Care Pharmacy Program (QCPP) and, therefore, compared with pharmacists, have a lesser level of personal experience with the facilitators. Another potential limitation is that a greater proportion of owner pharmacists responded to the survey than would be expected in the population18; thus, the results may not be generalizable to pharmacists in other positions.

The facilitators identified in this study reinforce the notion that successful practice change requires a multifactorial approach. It is clear that remuneration alone, for example, although a key factor, is not sufficient to achieve widespread change. Future programs for delivery in community pharmacy must address the wider issues of sustainability in calculating the rates of remuneration or incentive payments. Moreover, remuneration is only one factor within a broader solution incorporating elements relating to the overall organization—its individuals and environment. Implementing new CPS requires support not only with the clinical aspects of service delivery, but also for the process of implementation. Engagement of other healthcare providers and consumers is critical. Enhancing pharmacist–physician collaboration and consumer awareness of CPS will facilitate their uptake by community pharmacies.


    Conclusions
 Top
 Abstract
 Methods
 Results
 Discussion
 Limitations
 Conclusions
 References
 
Achieving integration of professional services into the business of a community pharmacy requires the effective engagement of pharmacists and their staffs, policy makers, educators, and researchers. At the pharmacy level, when preparing to implement CPS, there needs to be a plan for managing the change process that addresses the facilitators identified in this study. Policy makers have a key role in supporting community pharmacies to implement CPS. New services must be part of a greater strategic plan or change management strategy, and each service must have an implementation strategy that includes all of the individual and organizational elements outlined above. Education and training should also reflect these findings. Skills in areas such as leadership, task delegation, goal setting, and teamwork would seem to be of equal importance to pharmacists' clinical skills when it comes to integrating a new service into daily practice. It is critical that, at all levels of pharmacy practice, there is not only awareness, but also a commitment to use these facilitators to allow the profession to move forward in such a way that community pharmacy's role in service provision is strengthened.


    Footnotes
 
This work was presented orally and as an abstract entitled "Practice Change in Community Pharmacy: the Implementation of Cognitive Services" at the Australasian Pharmaceutical Science Association Scientific Meeting in Melbourne, Australia, 2006, and as a poster and abstract entitled "Implementing Change in Community Pharmacy: Facilitating Factors" at the Pharmaceutical Care Network Europe Working Conference in Hillerød, Denmark, 2005.

This project was funded by the Australian Government Department of Health and Ageing as part of the Third Community Pharmacy Agreement


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 Limitations
 Conclusions
 References
 

  1. Roberts AS, Benrimoj SI, Dunphy D, Palmer I. Community pharmacy: strategic change management. Sydney, Australia: McGraw-Hill,2007.
  2. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of facilitators of practice change. Int J Pharm Pract2006;14:163-70.[CrossRef]
  3. Fact Sheet. Fourth Community Pharmacy Agreement. Australian Government Department of Health and Ageing, 2005. www.health.gov.au/internet/wcms/publishing.nsf/Content/pharmacy4cpafact2 (accessed 2007 Oct 19).
  4. Benrimoj SI, Roberts AS. Providing patient care in community pharmacies in Australia. Ann Pharmacother2005;39:1911-7. Epub 11 Oct 2005. DOI 10.1345/aph.1G165[Abstract/Free Full Text]
  5. Johansen IBT. Implementing a pharmaceutical care program in community pharmacies: effects of organizational characteristics on implementation outcomes, in Pharmacy [PhD thesis]. Madison, WI: University of Wisconsin, 1999.
  6. Tindall WN, Millonig MK. Leadership and success: lessons from nonpharmacists. In: Tindall WN, Millonig MK, eds. Pharmaceutical care: insights from community pharmacists. Boca Raton, FL: CRC Press,2003: 49-62.
  7. Garside P. Organisational context for quality: lessons from the fields of organisational development and change management. Qual Health Care 1998;7(suppl):S8-15.
  8. Hopp TR, Sørensen EW, Herborg H, Roberts A. Implementation of cognitive pharmaceutical services (CPS) in professionally active pharmacies. Int J Pharm Pract2005;13:21-32.[CrossRef]
  9. Roberts AS, Hopp T, Sørensen EW, et al. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci2003;25:227-34.[CrossRef][Medline]
  10. The Commonwealth Department of Health and Ageing. Third Community Pharmacy Agreement Between The Commonwealth of Australia and The Pharmacy Guild of Australia. 2000.
  11. Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia's community pharmacies: Australia's National Pharmacy Database Project. Int J Pharm Pract 2007;15:185-91.[CrossRef]
  12. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Hopp TR, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Soc Admin Pharm2005;1:546-64.[CrossRef]
  13. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of models and frameworks for change. Int J Pharm Pract2006;14:105-13.[CrossRef]
  14. Roberts A, Benrimoj SI, Chen TF, Williams K, Aslani P. Quantification of facilitators to accelerate uptake of cognitive pharmaceutical services (CPS) in community pharmacy. 2004, University of Sydney. www.guild.org.au/public/r&d.asp#reports (accessed 2007 Oct 19).
  15. Pett MA, Lackey NR, Sullivan JJ. Making sense of factor analysis: the use of factor analysis for instrument development in health care research. Thousand Oaks, CA: Sage Publications,2003.
  16. Comrey AL, Lee HB. A first course in factor analysis. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates,1992.
  17. Dillman DA. Mail and telephone surveys. New York: John Wiley & Sons, 1978.
  18. Pharmacy labour force to 2001. In: Australian Institute of Health and Welfare, National Health Labour Force Series No. 25. Canberra, Australia,2003.
  19. Tabachnick BG, Fidell LS. Using multivariate statistics. 4th ed. Boston, MS: Allyn and Bacon, 2001.
  20. Graetz B. Principal components and factor analysis. Australian Consortium for Social and Political Research Incorporated Winter Program. Melbourne, Australia: La Trobe University,2003.
  21. de Vaus DA. Surveys in social research. 5th ed.Crows Nest, Sydney, Australia: Allen & Unwin,2002.
  22. Peterson RA. A meta-analysis of variance accounted for and factor loadings in exploratory factor analysis. Marketing Lett2000;11:261-75.[CrossRef]
  23. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementation of home medicines review (HMR) in community pharmacy. Aust Pharm 2005;24:808-13.
  24. Professional Programs and Services Advisory Committee. Australian Government Department of Health and Ageing, 2007. Diabetes pilot program questions and answers. www.health.gov.au/internet/wcms/publishing.nsf/Content/ppsac-qa-dpp (accessed 2007 Aug 21).
  25. Health Care Intelligence Pty Ltd. A study of the demand and supply of pharmacists, 2000–2010 [final report]. Sydney:2003. www.guild.org.au/uploadedfiles/Research_and_Development_Grants_Program/Projects/2001-501_fr.pdf (accessed 2007 Oct 19).
  26. Dolovich L, Ho CS, Wichman K, Bowles-Jordan J. The provision of enhanced pharmacy services in Ontario. Can Pharm J2002;135:29-36.
  27. Doucette WR, Koch YD. An exploratory study of community pharmacy practice change. J Am Pharm Assoc2000;40:384-91.
  28. MacKeigan L, Bennett M, Cable G, Buerki R. Cooperative model for developing a pharmaceutical care system in a community pharmacy. Presented at: American Association of Colleges of Pharmacy Annual Meeting,1994.
  29. Odedina FT, Segal R, Hepler C. Providing pharmaceutical care in community practice: differences between providers and non-providers of pharmaceutical care. J Soc Admin Pharm1995;12:170-80.
  30. Tully MP, Seston EM, Cantrill JA. Motivators and barriers to the implementation of pharmacist-run prescription monitoring and review services in two settings. Int J Pharm Pract2000;8:188-97.
  31. Australian Government Department of Health and Ageing,2007. Professional programs and services. www.health.gov.au/internet/wcms/publishing.nsf/Content/ppsac-pps (accessed 2007 Oct 19).




This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, A. S
Right arrow Articles by Aslani, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, A. S
Right arrow Articles by Aslani, P.


homecopy help contact us subscription past issues search current issue